These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19404928)

  • 21. Graves' disease in a patient with rheumatoid arthritis during treatment with anti-tumor necrosis factor-alpha.
    van Lieshout AW; Creemers MC; Radstake TR; Elving LD; van Riel PL
    J Rheumatol; 2008 May; 35(5):938-9. PubMed ID: 18464319
    [No Abstract]   [Full Text] [Related]  

  • 22. [Rheumatoid polyarthritis: a new treatment].
    Perspect Infirm; 2010; 7(5):46-7. PubMed ID: 21744636
    [No Abstract]   [Full Text] [Related]  

  • 23. Tocilizumab for rheumatoid arthritis with chronic hepatitis B virus infection without antiviral therapy.
    Nagashima T; Minota S
    J Rheumatol; 2010 May; 37(5):1066; author reply 1067. PubMed ID: 20439526
    [No Abstract]   [Full Text] [Related]  

  • 24. Rheumatoid arthritis.
    Burchini G; Orsi C
    N Engl J Med; 2004 Sep; 351(13):1360-1; author reply 1360-1. PubMed ID: 15385669
    [No Abstract]   [Full Text] [Related]  

  • 25. New and promising treatments for rheumatoid arthritis.
    Looney RJ; Stohl W
    Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):18-23. PubMed ID: 17694190
    [No Abstract]   [Full Text] [Related]  

  • 26. [Kineret, Enbrel, Remicade and company. Recombinant drugs in rheumatoid arthritis].
    Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2003; 32(5):376-83. PubMed ID: 14526457
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacotherapy of rheumatoid arthritis in the era of genetically engineered biological preparations].
    Nasonov EL
    Ter Arkh; 2007; 79(5):5-8. PubMed ID: 17672066
    [No Abstract]   [Full Text] [Related]  

  • 28. Longterm treatment benefits are best reflected by patient reported outcomes.
    Strand CV; Crawford B
    J Rheumatol; 2007 Dec; 34(12):2317-9. PubMed ID: 18061963
    [No Abstract]   [Full Text] [Related]  

  • 29. New drugs for rheumatoid arthritis.
    Messori A; Santarlasci B; Vaiani M
    N Engl J Med; 2004 Aug; 351(9):937-8. PubMed ID: 15329436
    [No Abstract]   [Full Text] [Related]  

  • 30. FDA OKs two new uses for biologic arthritis drug adalimumab.
    Health News; 2006 Jan; 12(1):2. PubMed ID: 16447312
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].
    González-Gay MA; Agudo M
    Med Clin (Barc); 2010 May; 134(15):684-5. PubMed ID: 20176386
    [No Abstract]   [Full Text] [Related]  

  • 32. When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step?
    Smolen JS; Weinblatt ME
    Ann Rheum Dis; 2008 Nov; 67(11):1497-8. PubMed ID: 18854512
    [No Abstract]   [Full Text] [Related]  

  • 33. Which TNF inhibitor for rheumatoid arthritis?
    Med Lett Drugs Ther; 2010 May; 52(1338):38-9. PubMed ID: 20467356
    [No Abstract]   [Full Text] [Related]  

  • 34. [Biological agents for therapy of rheumatoid arthritis--overview].
    Takeuchi T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():513-6. PubMed ID: 15799409
    [No Abstract]   [Full Text] [Related]  

  • 35. Dermatomyositis during adalimumab therapy for rheumatoid arthritis.
    Brunasso AM; Scocco GL; Massone C
    J Rheumatol; 2010 Jul; 37(7):1549-50. PubMed ID: 20595297
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cutaneous rash from the use of medicine for rheumatoid arthritis].
    Hannuksela M
    Duodecim; 2006; 122(1):105, 111. PubMed ID: 16509198
    [No Abstract]   [Full Text] [Related]  

  • 37. Comment on "Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks" by Yokoe et al.
    Nagashima T; Okazaki H; Kamata Y; Minota S
    Mod Rheumatol; 2012 Aug; 22(4):638-9; authoe reply 640-2. PubMed ID: 22669601
    [No Abstract]   [Full Text] [Related]  

  • 38. Nucleosome accumulation and reduction of C-reactive protein are associated with the generation of anti-nuclear antibodies in patients with rheumatoid arthritis treated with adalimumab, but not with etanercept.
    Priori R; Alessandri C; Magrini L; Cassarà EA; Ceccarelli F; Modesti M; Croia C; Bombardieri M; Valesini G
    Ann Rheum Dis; 2009 Sep; 68(9):1514-6. PubMed ID: 19674992
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Scott DL; Kingsley GH
    N Engl J Med; 2006 Aug; 355(7):704-12. PubMed ID: 16914706
    [No Abstract]   [Full Text] [Related]  

  • 40. Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab.
    Ogata A; Morishima A; Hirano T; Hishitani Y; Hagihara K; Shima Y; Narazaki M; Tanaka T
    Ann Rheum Dis; 2011 Jun; 70(6):1164-5. PubMed ID: 20980285
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.